Product information

Current status:

Cancelled Post Market

Current status date:

2013-08-02

Original market date: ^{See footnote 1}

2000-06-20

Product name:

APO-DILTIAZ INJECTABLE

DIN:

02241253 Electronic product monograph is not available

Company:

APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada M9L 1T9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

24:28.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

C08DB01 DILTIAZEM

Active ingredient group (AIG) number:^{See footnote5}

0115863003